How Spain Became Big Pharma’s New Hotspot in Europe
- Miguel Virgen, PhD Student in Business
- Apr 2, 2025
- 3 min read
Updated: Apr 24, 2025
April (Doctors In Business Journal) - Spain’s Rise as a Life Sciences Powerhouse: Spain has emerged as Europe’s leading destination for pharmaceutical research and development, overtaking traditional leaders in clinical trials and attracting significant investment in the life sciences sector. With its robust healthcare infrastructure, skilled workforce, and government support, the country is now a critical hub for pharmaceutical innovation. However, it faces intense competition from other global players, including China.
Want to read more?
Subscribe to doctorsinbusinessjournal.com to keep reading this exclusive post.
